Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Hydration with Lactated Ringer’s solution combined with rectal diclofenac in t...
Journal Information
Vol. 44. Issue 1.
Pages 20-26 (January 2021)
Download PDF
More article options
Vol. 44. Issue 1.
Pages 20-26 (January 2021)
Original article
DOI: 10.1016/j.gastre.2020.12.001
Hydration with Lactated Ringer’s solution combined with rectal diclofenac in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography
Hidratación con Ringer Lactato combinado con diclofenaco rectal en la prevención de pancreatitis poscolangiopancreatografía retrógrada endoscópica
M. Lourdes del Olmo Martíneza,
Corresponding author

Corresponding author.
, Benito Velayos Jiméneza, Ana Almaraz-Gómezb
a Servicio de Aparato Digestivo, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
b Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad Valladolid, Valladolid, Spain
Article information
Full Text
Download PDF
Tables (3)
Table 1. Baseline characteristics of the different groups of patients.
Table 2. Results of the bivariate analysis relating to the influence of the different factors studied on the likelihood of developing post-ERCP pancreatitis.
Table 3. Significant results from the logistic regression analysis with patient-related and ERCP-related variables that could be confounding factors in the development of post-ERCP pancreatitis.
Show moreShow less

Different measures are recommended to reduce pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). We conducted a study in patients with ERCP treated with rectal diclofenac or lactated Ringer’s solution, or both interventions, to assess whether there is a decrease in the number of cases of post-ERCP pancreatitis.

Material and methods

A mixed cohort study involving 1896 patients from 2009 to 2018. Up to June 2012 without treatment (Group I). Subsequently, 100 mg of rectal diclofenac (Group II). Since 2016, lactated Ringer’s solution 200 ml/h during the procedure and 4 h after it, in addition to 500 ml over 30 min when the pancreas was cannulated (Group III). Since 2017, lactated Ringer’s solution plus Diclofenac (Group IV). There were 725 patients in group I, and 530, 227 and 414 patients in groups II, III and IV, respectively. Factors predisposing to post-ERCP pancreatitis and post-ERCP pancreatitis cases that were defined by consensus criteria have been collected.


There were 65 cases of post-ERCP pancreatitis (3.4%); 2.9%, 3.4%, 3.1% and 4.3% in groups I, II, III and IV, respectively (p = .640). In group I, there was 4.2% of post-ERCP pancreatitis in naïve papillae and 4%, 4.9% and 6.3% in groups II, III and IV, respectively (p = .585). The severity of post-ERCP pancreatitis and adverse effects were similar in all groups. 38.4% were high-risk patients. There were also no differences in post-ERCP pancreatitis in this group (p = .501).


In this work, no benefit was obtained with diclofenac plus hydration in reducing the number and severity of cases of post-ERCP pancreatitis nor with the other prophylactic measures.

Lactated Ringer’s

Se aconsejan diferentes medidas para disminuir la pancreatitis post-colangiopancreatografía retrógrada endoscópica (PPCPRE). Efectuamos un estudio en pacientes con CPRE tratados con Diclofenaco rectal o Ringer Lactato o bien ambas intervenciones para valorar si existe una disminución en el número de PPCPRE.

Material y métodos

Estudio de cohortes mixto con 1.896 pacientes desde 2009 hasta 2018. Hasta junio de 2012 sin tratamiento (grupo I). Posteriormente 100 mg de diclofenaco rectal (grupo II). Desde 2016 Ringer Lactato 200 ml/h durante el procedimiento y 4 h después del mismo, además 500 ml en 30 min cuando se canuló el páncreas (grupo III). Desde 2017 Ringer Lactato más diclofenaco (grupo IV). Hubo 725 pacientes en el grupo i, 530, 227 y 414 pacientes en grupos II, III y IV. Se han recogido factores predisponentes a PPCPRE y los casos de PPCPRE que fue definida por criterios de consenso.


Hubo 65 PPCPRE (3,4%); 2,9; 3,4; 3,1 y 4,3% en los grupos I, II, III y IV respectivamente (p = 0,640). En el grupo I hubo un 4,2% de PPCPRE en papilas naïve y un 4; 4,9% y 6,3% en los grupos II, III y IV respectivamente (p = 0,585). La gravedad de PPCPRE y los efectos adversos fueron similares en los grupos. El 38,4% eran pacientes de alto riesgo. Tampoco hubo diferencias de PPCPRE en este grupo (p = 0,501).


En este trabajo no se ha obtenido beneficio con diclofenaco más hidratación en la disminución del número y gravedad de la PPCPRE. Tampoco con las otras medidas profilácticas.

Palabras clave:
Ringer Lactato


These are the options to access the full texts of the publication Gastroenterología y Hepatología (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Gastroenterología y Hepatología (English Edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos